Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 172

Similar articles for PubMed (Select 23990457)

1.

XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.

Huang Y, Xie D, Tang N, Wang J, Zeng X, Zhao P, He L.

Tumour Biol. 2014 Jan;35(1):799-808. doi: 10.1007/s13277-013-1110-7. Epub 2013 Aug 30.

PMID:
23990457
2.

Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.

Jiang L, Fang X, Bao Y, Zhou JY, Shen XY, Ding MH, Chen Y, Hu GH, Lu YC.

PLoS One. 2013;8(1):e55597. doi: 10.1371/journal.pone.0055597. Epub 2013 Jan 30.

3.

X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.

Zeng FR, Ling Y, Yang J, Tian XC, Yang X, Luo RC.

Tumour Biol. 2013 Feb;34(1):555-63. doi: 10.1007/s13277-012-0581-2. Epub 2012 Nov 28.

PMID:
23188703
4.

X-ray repair cross-complementing gene 1 Arg399Gln polymorphism and glioma risk among Asians: A meta-analysis based on 2 326 cases and 3 610 controls.

Zhang L, Qiu Z, Luo J, Shu W.

Neural Regen Res. 2012 Oct 15;7(29):2313-9. doi: 10.3969/j.issn.1673-5374.2012.29.011.

5.

Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.

Saadat M, Ansari-Lari M.

Breast Cancer Res Treat. 2009 May;115(1):137-44. doi: 10.1007/s10549-008-0051-0. Epub 2008 May 15.

PMID:
18481169
6.

XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls.

Zhuo W, Zhang L, Cai L, Zhu B, Chen Z.

Exp Biol Med (Maywood). 2013 Jan;238(1):66-76. doi: 10.1258/ebm.2012.012209.

PMID:
23479765
7.

Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.

Li J, Li Z, Feng L, Guo W, Zhang S.

Tumour Biol. 2013 Feb;34(1):261-9. doi: 10.1007/s13277-012-0546-5. Epub 2012 Oct 6.

PMID:
23055199
8.

XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.

Qi Y, Cui L, Song Y, Li N.

Mol Biol Rep. 2014 Feb;41(2):879-87. doi: 10.1007/s11033-013-2929-0. Epub 2014 Jan 4.

PMID:
24390232
9.

MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.

Zhuo W, Zhang L, Ling J, Zhu B, Chen Z.

Leuk Lymphoma. 2012 Nov;53(11):2245-52. doi: 10.3109/10428194.2012.691485. Epub 2012 Jun 12.

PMID:
22563815
10.

XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.

Liu B, Shen T.

Tumour Biol. 2014 Jan;35(1):507-12. doi: 10.1007/s13277-013-1071-x. Epub 2013 Sep 20.

PMID:
24052436
11.

XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis.

Wang R, Hu X, Zhou Y, Feng Q, Su L, Long J, Wei B.

Leuk Lymphoma. 2013 Jan;54(1):153-9. doi: 10.3109/10428194.2012.704031. Epub 2012 Jul 9.

PMID:
22712837
12.
13.

XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.

Liu F, Li B, Wei Y, Yan L, Wen T, Zhao J, Xu M.

Liver Int. 2011 Jul;31(6):802-9. doi: 10.1111/j.1478-3231.2011.02508.x. Epub 2011 Mar 21. Review.

PMID:
21645210
14.

Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.

Dong LM, Zhang XY, Teng H, Li MS, Wang P.

Genet Mol Res. 2014 Nov 28;13(4):9976-85. doi: 10.4238/2014.November.28.2.

15.

Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls.

Zhuo W, Zhang L, Zhu B, Qiu Z, Chen Z.

PLoS One. 2012;7(10):e46974. doi: 10.1371/journal.pone.0046974. Epub 2012 Oct 4.

16.

XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population.

Warchoł T, Mostowska A, Lianeri M, Lącki JK, Jagodziński PP.

DNA Cell Biol. 2012 Jan;31(1):50-6. doi: 10.1089/dna.2011.1246. Epub 2011 Jun 17.

17.

DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.

Trabulus S, Guven GS, Altiparmak MR, Batar B, Tun O, Yalin AS, Tunckale A, Guven M.

Mol Biol Rep. 2012 Jun;39(6):6995-7001. doi: 10.1007/s11033-012-1529-8.

PMID:
22302399
18.

XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.

Hu Z, Hu X, Long J, Su L, Wei B.

Gene. 2013 Oct 10;528(2):67-73. doi: 10.1016/j.gene.2013.07.005. Epub 2013 Jul 17.

PMID:
23872202
19.

Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study.

Saadat M, Kohan L, Omidvari S.

Breast Cancer Res Treat. 2008 Oct;111(3):549-53. Epub 2007 Nov 7.

PMID:
17987379
20.

X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.

Wang L, Yin F, Xu X, Hu X, Zhao D.

PLoS One. 2012;7(4):e34897. doi: 10.1371/journal.pone.0034897. Epub 2012 Apr 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk